Small molecule · developed by ImmunityBio
5-Fluorouracil is a small molecule, chemically 5-fluoro-2,4(1H,3H)-pyrimidinedione, studied in urothelial carcinoma.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT03197571 | Phase 1/2 | Urothelial Carcinoma | Withdrawn | IBRX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Urothelial Carcinoma
Updated Nov 8, 2026. Something wrong or missing? Report it on the IBRX page.
See IBRX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
IBRX catalysts and pipeline →